Allertec WZF

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allertec WZF

Allertec WZF is a pharmaceutical product defined by its active ingredient, Cetirizine Dihydrochloride, and is classified as a modern second-generation H1 antihistamine. It is a synthetic, single-component drug, clinically recognized for its high affinity and selectivity for peripheral histamine receptors.

Quick Facts Description
Active Ingredient Cetirizine Dihydrochloride (INN)
Form Film-coated tablet
Pharmacological Class Second-generation H1 Antihistamine
Common Use Anti-allergic agent
Origin Synthetic (Piperazine derivative)

What Type of Medicine is Allertec WZF?

Allertec WZF belongs to the pharmacological class of second-generation H1 antihistamines. This classification reflects its design for selective action on peripheral histamine H1 receptors, minimizing its ability to cross the blood-brain barrier compared to older, first-generation drugs. This reduced central nervous system penetration is a key differentiating feature. The medical consensus is that this selective profile ensures the drug effectively counters the effects of histamine while generally limiting potential sedative effects, making it a well-tolerated option for use.

Active Ingredient and Pharmaceutical Form

The active component in Allertec WZF is Cetirizine Dihydrochloride, which is the sole pharmacologically active substance. This synthetic agent is prepared as a film-coated tablet for oral administration. The tablet formulation, which contains the standardized dose of the active substance, is recognized for its convenience as a once-daily formulation. The product’s consistent, standardized dosage makes it a common choice for individuals seeking relief from daily allergy symptoms.

General Purpose of Allertec WZF

The general purpose of Allertec WZF is to act as a focused anti-allergic agent. Its function is based on selective H1-receptor antagonism, a process where the active ingredient binds to and blocks the peripheral histamine H1 receptors. By preventing histamine—the substance released during allergic responses—from activating these sites, the drug suppresses the physiological reaction, thereby alleviating the general manifestations associated with allergies, such as itching or swelling.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Allertec WZF?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety constraints for Allertec WZF (cetirizine) as documented in official government regulatory information.

Frequency-Classified Adverse Reactions

The following side effects are classified according to their documented frequency:

  • Common (may affect up to 1 in 10 people): Somnolence (drowsiness), fatigue, headache, dizziness, dry mouth, nausea, pharyngitis, and rhinitis (in children).
  • Uncommon (may affect up to 1 in 100 people): Agitation, paresthesia, diarrhoea, abdominal pain, pruritus (itching), rash, and asthenia (extreme weakness).
  • Rare (may affect up to 1 in 1,000 people): Tachycardia (fast heartbeat), oedema (swelling), weight increase, and abnormal liver function test results (increased transaminases, bilirubin).
  • Very Rare (may affect up to 1 in 10,000 people): Thrombocytopenia (low platelet count), urinary retention, tremor, dystonia, and anaphylactic shock.
  • Frequency Not Known: Increased appetite, suicidal ideation, amnesia, memory impairment, and severe itching or hives upon discontinuation.

Serious Adverse Reactions and Safety Constraints

Serious adverse reactions listed in regulatory documents include anaphylactic shock and other severe hypersensitivity reactions (e.g., angioedema). Hepatic function abnormality has also been reported as rare.

Population-Specific Safety Notes

Allertec WZF is contraindicated in patients with severe renal impairment (Creatinine clearance less than 10 mL/min). Dosage adjustments are mandatory for patients with moderate to mild renal impairment. Caution is recommended for use in the elderly due to the higher likelihood of reduced kidney function.

Safety Restrictions

  • Contraindications: Do not use if there is a known hypersensitivity to the drug, hydroxyzine, or other piperazine derivatives.
  • Precautionary Statements: Caution is advised in patients with predisposing factors for urinary retention and in epileptic patients or those at risk of convulsions.
  • Interference: It is recommended to discontinue the medication three days prior to allergy skin testing, as it may inhibit the test reaction.

Overdose and Emergency Response

The official regulatory guidance for Allertec WZF (Cetirizine Dihydrochloride) overdose mandates seeking immediate medical attention if overdosage is suspected or confirmed. The documentation identifies a primary symptom cluster involving the Central Nervous System (CNS), with the most frequently reported manifestation being somnolence or drowsiness. Severe CNS effects, including stupor and confusion, are also officially documented in the prescribing information.

Beyond CNS effects, an overdose may present with documented systemic manifestations such as tachycardia (increased heart rate), tremor, and urinary retention. Gastrointestinal effects, including diarrhoea and abdominal pain, have also been noted. Specific case reports of overdosage in pediatric patients (e.g., an 18-month-old) confirm initial restlessness and irritability followed by drowsiness.

Official emergency management is defined by the fact that there is no known specific antidote to cetirizine. Therefore, the required intervention is strictly symptomatic or supportive treatment. Healthcare professionals may consider procedures like gastric lavage shortly after acute ingestion to aid management. Patients must contact emergency services or a poison control center immediately to ensure appropriate clinical care is initiated.

Therapeutic Uses of Allertec WZF

The primary therapeutic role of Allertec WZF is used to provide symptomatic relief across key domains of allergic disease, supporting comfort in episodes where symptoms are driven by the body’s allergic response. These therapeutic domains include respiratory and dermatological allergies.

This medication is commonly used across conditions presenting with episodic or fluctuating symptom patterns, including seasonal and perennial allergic rhinitis (hay fever), allergic conjunctivitis, and acute and chronic urticaria (hives). It is relevant for managing symptom clusters that may appear suddenly or fluctuate, such as repetitive sneezing, runny nose, body itching (pruritus), and raised wheals. The therapeutic benefit may be relevant for easing symptoms that create noticeable physiological strain.

“The primary benefit is focused on providing supportive relief from the physical discomforts of allergic symptoms, which supports patients during difficult episodes by easing distress.”


Quick Fact Symptom Domain
Common Indication Seasonal and year-round allergic rhinitis
Dermal Manifestations Itching, hives, and wheals (urticaria)
Ocular Manifestations Itchy, watery, and red eyes

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Allertec WZF

Official regulatory documents define specific populations permitted to use Allertec WZF (cetirizine dihydrochloride) and those for whom its use is strictly prohibited or restricted.


Category Status (Regulatory Wording)
Populations for whom use is allowed Adults and Adolescents; Children aged 6 years and older (tablet formulation).
Populations for whom use is not recommended Children under 6 years of age (tablet formulation); Pregnant and Lactating women.

Contraindicated Populations

The medicine is contraindicated in patients with a known hypersensitivity to the active substance, to any formulation excipients, to hydroxyzine, or to any piperazine derivatives. Use is also strictly prohibited in patients with severe renal impairment (creatinine clearance less than 10 mL/min).

Condition-Specific Restrictions

For patients with mild or moderate renal impairment, or those with combined hepatic and renal impairment, use is restricted and necessitates individual adjustment. Caution is advised for patients with predisposing factors for urinary retention or those with a history of epilepsy or risk of convulsions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Allertec WZF (cetirizine dihydrochloride) documents specific interaction patterns concerning pharmacodynamic and pharmacokinetic mechanisms.


Pharmacodynamic and CNS Interactions

Co-administration with Alcohol and other Central Nervous System (CNS) Depressants may result in a pharmacodynamic additive effect. This is documented as potentially causing additional impairment of performance and reductions in alertness, particularly in sensitive individuals. Precaution is recommended when using these substances concurrently.


Pharmacokinetic Drug-Drug Interactions

Formal interaction studies have identified specific alterations in cetirizine's clearance. Co-administration of Theophylline at a daily dose of 400 mg results in a 16% decrease in the clearance of cetirizine. The kinetics of Theophylline, however, are not reported to be altered. Conversely, studies with other drugs, including Azithromycin, Erythromycin, Ketoconazole, and Pseudoephedrine, showed no clinically significant pharmacokinetic interactions.


Food and Population Considerations

The drug’s interaction with food is limited to a kinetic effect: food does not change the overall extent of exposure but decreases the rate of absorption, delaying the time to peak plasma concentration. Furthermore, a reduced clearance of cetirizine is documented in patients with renal or hepatic impairment. This reduction in elimination amplifies the systemic exposure, thereby increasing the potential risk of all documented concentration-dependent interaction effects.

Mechanism of Action

The mechanism of Allertec WZF is confined to its pharmacodynamic action, which involves precisely modulating key signaling pathways activated during specific physiological responses. The drug's activity exhibits selectivity for the peripheral Histamine H1 Receptor ( H1 R) and minimal interaction with other receptor types.


Targeted Blockade of Peripheral H1 Receptors

The core mechanism involves Cetirizine acting as an inverse agonist that binds to the peripheral H1 R. This interaction stabilizes the receptor in an inactive state, which prevents the binding of the inflammatory messenger histamine and reduces H1 R-mediated signaling in peripheral tissues.


Modulation of Vascular Permeability and Sensory Signaling

By blocking the H1 R on vascular endothelial cells and peripheral nerve endings, the drug modifies critical system-level functions. This molecular intervention inhibits the histamine-induced increase in capillary permeability and inhibiting histamine-mediated activation of peripheral sensory nerves, modulating the resulting physiological response in the target tissues.

Dosage and Administration Information

How to Use Allertec WZF

Allertec WZF is administered through the oral route using its film-coated tablet formulation. The drug is generally intended for a once-daily schedule, which establishes a consistent 24-hour dosing rhythm. The tablets are designed to be swallowed whole and must be taken with a glass of liquid. Administration is flexible and not dependent on meals, meaning the dose can be taken with or without food.


Standard Dosage and Population-Specific Adjustments

The standard once-daily dose for adults and adolescents 12 years and older is 10 mg. While 10 mg is the standard, a lower initial dose of 5 mg once daily may be used in certain contexts to achieve satisfactory relief.

Population Group Standard Regimen Special Procedural Instruction
Adults (Standard) 10 mg once daily May start at 5 mg once daily
Children (6–12 years) 5 mg twice daily The tablet form is not recommended for children under 6 years
Renal Impairment Dose is reduced (e.g., 5 mg daily or 5 mg every 2 days) Dosing must be adjusted based on Creatinine Clearance

Procedural Administration Notes

The duration of use is determined by the specific allergic condition being managed and can vary from short-term use for acute episodes to a longer-term regimen covering an entire allergy season. If a dose is missed, it should be taken when remembered unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped to prevent taking a double dose. This protocol maintains the safe administration framework.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Allertec WZF


Evidence for Use in Seasonal Allergic Rhinitis (Hay Fever)

Research has examined the substance in adults with seasonal allergic rhinitis, a condition characterized by fluctuating or episodic manifestations of nasal and eye symptoms during specific times of the year. These have typically been short-term randomized controlled trials (RCTs) used in research exploring how symptoms change over time. Studies monitored outcomes linked to inflammatory or irritative states.

The findings describe patterns observed in the studies where participants receiving the substance reported measurements of mean changes in symptom scores over the short study period compared to the inactive comparison. However, follow-up durations were limited, meaning these observations relate primarily to short-term changes. Long-term effects are not fully established regarding sustained patterns of patient-reported experience over multiple seasons.


Evidence for Use in Perennial Allergic Rhinitis

The substance was studied for use in perennial allergic rhinitis, a condition involving periods of heightened symptoms that occur year-round. Research describes changes measured during the study period in symptom scores, showing patterns related to the substance's use compared to placebo. Studies contribute to the broader evidence landscape by providing insight into short-term changes in populations experiencing continuous symptom burdens.

Certainty remains low regarding whether the substance's observed actions persist consistently when symptoms may vary in intensity across seasons, as limited information is available for long-term outcomes in this context.


Evidence for Use in Chronic Urticaria (Hives)

Research examined the substance in populations with chronic urticaria, a condition marked by functional limitations and the appearance of hives (welts) that may vary in intensity. Studies monitored outcomes related to physical discomfort, primarily measuring changes in the number and size of hives and the severity of associated itching.

Findings describe patterns observed in the studies, and the substance's use was associated with patterns of reported changes in patient experience during the short observation period. Sample sizes were modest in some of the studies, limiting the generalizability of the reported observations.


What is Still Uncertain About Allertec WZF

A significant area of uncertainty is that long-term effects are not fully established across any of the indications, as follow-up durations were limited in many key studies. Data for certain groups remain insufficient, particularly for very young children and older adults with specific co-morbidities. Evidence quality varies across studies, and comparative evidence is lacking when considering the substance against all available alternatives. This highlights that research is ongoing and more data are needed to fully characterize the research landscape.

Key Studies & References

  1. H1-Antihistamines (First- and Second-Generation) for Seasonal Allergic Rhinitis

Frequently Asked Questions (FAQ)

Common questions about Allertec WZF (FAQ)

Q: Is Allertec WZF the same as Zyrtec or other allergy pills?

A: Allertec WZF contains the active substance cetirizine dihydrochloride. This is the same active ingredient found in certain other branded antihistamine products, such as Zyrtec, and is generally classified as a second-generation H1 antihistamine. The official classification indicates that its primary function is focused on allergy symptom relief.

Q: How quickly does Allertec WZF start working after I take it?

A: Studies and official reports indicate that the effects of the active substance, cetirizine, generally begin within approximately thirty minutes following oral administration. The onset of effect may vary among individuals.

Q: How long do the effects of Allertec WZF last?

A: The effects of the active substance are described in official documents as lasting for approximately a day. This duration is consistent with the standard once-daily administration schedule for the medicine.

Q: Can Allertec WZF be taken every day for chronic allergies?

A: Regulatory documents indicate that the medicine is used for both short-term, seasonal symptoms and for longer-term regimens associated with perennial allergic rhinitis or chronic urticaria. Official safety warnings indicate that severe itching or hives have been reported upon discontinuation following long-term daily use.

Q: Is Allertec WZF permitted for use in children?

A: The film-coated tablet formulation is indicated for use in children aged 6 years and over. Official adverse reaction listings note that certain side effects, such as rhinitis (nasal irritation) and pharyngitis (sore throat), have been commonly reported in children.

Q: Can Allertec WZF be taken with pain relievers like ibuprofen or paracetamol?

A: Formal drug interaction studies on the active substance have not found clinically significant pharmacokinetic interactions with certain medicines examined. However, the regulatory documents do not specifically list studies conducted with ibuprofen or paracetamol.

Q: Are there any specific foods or drinks that should be avoided when taking Allertec WZF?

A: The official product information indicates the drug is not dependent on meals and can be taken with or without food. Official documents describe that co-administration with alcohol or other substances that depress the Central Nervous System (CNS) may result in an additive effect. This is documented as potentially causing additional impairment of performance and reductions in alertness.

Q: Why do some people say Allertec WZF made them feel more nervous or restless?

A: Official adverse reaction documents list 'Agitation' as an uncommon side effect, which may affect up to 1 in 100 people. Additionally, 'Nervousness' has been reported as a post-marketing event for the active substance.

Q: Does Allertec WZF help with non-allergy symptoms like general congestion?

A: The medicine is officially indicated for symptoms directly associated with allergic conditions, such as allergic rhinitis and chronic urticaria. It is not indicated for non-allergic general cold symptoms.

Q: Is there any research that compares the effect of Allertec WZF to a placebo?

A: Official summaries of the research evidence for the active substance confirm that studies have included short-term randomized controlled trials (RCTs). In these studies, participants receiving the substance were compared to an inactive comparison, often referred to as a placebo.

Q: What kind of studies have been done on Allertec WZF's effectiveness?

A: Research on the active substance primarily consists of short-term randomized controlled trials (RCTs). These studies were used to explore how symptom scores change over the observation period in officially indicated conditions, such as seasonal allergic rhinitis and chronic urticaria.

Q: Is it normal to feel a little dizzy after taking Allertec WZF?

A: Official adverse reaction documents list 'Dizziness' as a common side effect for the active substance. This is described as a common side effect in official reports.

Q: Why is Allertec WZF sometimes prescribed for people with asthma (in general)?

A: While the drug is not indicated solely for asthma, regulatory-cited studies have examined its use in specific patient populations who have coexisting allergic rhinitis and mild-to-moderate asthma. These studies reported associated patterns of change in asthma symptoms in those particular groups.

Q: Do I need to eat food when I take Allertec WZF?

A: The official product information indicates that the dose can be taken with or without food. Administration is flexible and is not dependent on meals to ensure effectiveness.

Q: Is it true that Allertec WZF might affect certain blood tests?

A: Regulatory documents indicate that abnormal liver function test results have been reported in rare cases. Additionally, the medicine is recommended to be discontinued three days prior to allergy skin testing, as it may inhibit the test reaction.

Q: Can taking Allertec WZF make my eyes feel drier?

A: Although 'dry mouth' is listed as a common side effect for the oral formulation, 'dry eyes' is not explicitly listed as a common adverse reaction in official product information. Some adverse event monitoring data includes reports related to ocular dryness.

Q: Is Allertec WZF suitable for people with lactose intolerance?

A: The tablet formulation of Allertec WZF contains lactose monohydrate as an inactive ingredient. Official guidance notes that the presence of this excipient makes the product unsuitable for patients with known rare hereditary problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.

Q: Why is the active substance in Allertec WZF also used in other drugs?

A: The active substance, cetirizine, is a well-established second-generation antihistamine that is included on the World Health Organization's Model List of Essential Medicines. It is used in various preparations and formulations because it is recognized as a key tool for treating allergic conditions.

Q: Does Allertec WZF have a known effect on blood pressure?

A: Tachycardia, which is a fast heartbeat, is listed as a rare side effect. Official documents do not typically cite the medicine as having a known effect on blood pressure when used as a single agent.

Q: Is it okay to stop taking Allertec WZF suddenly?

A: Official safety warnings indicate that severe itching or hives (pruritus and/or urticaria) have been reported upon sudden discontinuation, particularly following long-term daily use. This is a pattern noted in post-marketing safety data.

Q: Does Allertec WZF interact with common herbal supplements like St. John's Wort?

A: Formal interaction studies do not specifically list St. John's Wort. Because St. John's Wort has the potential to cause nervous system side effects like dizziness and drowsiness, a consideration is recommended if co-administering with medicines known to have CNS depressant effects.

Q: Why do some users report a decrease in effectiveness over time?

A: Studies have examined the potential for a decrease in drug effectiveness, often referred to as tachyphylaxis, over extended use. Research specifically examining up to 180 days of continuous treatment with cetirizine did not observe this phenomenon regarding its antihistamine effect.

Q: Is Allertec WZF used for symptoms related to pet allergies?

A: The medicine is officially indicated for the relief of symptoms due to allergic rhinitis, both seasonal and perennial, and chronic idiopathic urticaria. Allergic rhinitis symptoms, regardless of the specific allergen like pet dander, are included in the overall conditions for which the drug is used.

Q: Can Allertec WZF be used for general cold symptoms that are not strictly allergic?

A: The official indications limit the use of the medicine to the relief of symptoms specifically caused by allergic conditions, such as allergic rhinitis and chronic urticaria. It is not indicated for non-allergic general cold symptoms.

Q: How is Allertec WZF different from products that use diphenhydramine?

A: Allertec WZF (cetirizine) is categorized as a second-generation H1 antihistamine. This class is designed for selective action with minimal ability to cross the blood-brain barrier. Diphenhydramine is a first-generation antihistamine, known for having higher central nervous system penetration.

Q: Is there a maximum time recommended for continuous use of Allertec WZF?

A: The duration of use is determined by the specific condition being managed. Regulatory advice for chronic urticaria suggests that if antihistamines are needed continuously for more than six weeks, official guidance recommends evaluating the necessity of continuing the regimen.

Q: What is the 'WZF' part of the name Allertec WZF?

A: The letters 'WZF' are an abbreviation that refers to Zakłady Farmaceutyczne Polpharma S.A. This company is listed as the manufacturer for the product in certain regions.

Q: What are the official guidelines regarding use of Allertec WZF before driving?

A: Official regulatory information advises that patients who experience somnolence (drowsiness) should refrain from driving or engaging in potentially hazardous activities. It is noted that patients should not exceed the prescribed dose. Individuals are recommended to be aware of their personal reaction to the medication before engaging in potentially hazardous activities.

Q: What is the typical time frame cited for seeing the maximum effect of Allertec WZF?

A: Studies on the active substance, cetirizine, indicate that the time to reach maximum concentration in the blood, known as Tmax, is approximately one hour after oral administration. The rate of this absorption may be delayed if the medication is taken with food.

Q: What is the purpose of the excipients (non-active ingredients) in Allertec WZF tablets?

A: Official drug labels list the inactive ingredients (excipients), which may include substances like lactose monohydrate and magnesium stearate. These components are included in the tablet formulation to help form the tablet, maintain product stability, and aid in the overall manufacturing process.

How should Allertec WZF be stored and disposed of?

Storage and Disposal Requirements

The storage and disposal of Allertec WZF (Cetirizine 10 mg film-coated tablets) are strictly governed by regulatory instructions to maintain product stability and ensure public safety.

Storage Condition Regulatory Requirement
Temperature Store below 25 C
Protection Must be kept in the original outer packaging to protect from light and moisture
Child Safety Mandatory to store the medicine in a place inaccessible and invisible to children
Shelf-Life Do not use after the expiration date printed on the packaging

For disposal, the regulatory guidance states that the medicine must not be placed in household waste or flushed into the sewage system. Unused or expired medication should be disposed of by consulting a pharmacist, who can advise on the proper pharmaceutical waste handling procedure to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allertec WZF found in:

A-Z Index: